Fig. 2From: The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cellsCD166+ OSCs is associated with a kinase switch that enables EGFR-independent activation of AKT. Western-blotting was used with antibodies specific for phosphorylated and total EGFR, HER2, AKT, FGFR, and p-FAK, Vimentin, E-Cadherin. GAPDH was used as the controlBack to article page